Cover Image
市場調查報告書

中國的豬隻繁殖、呼吸障礙症候群(PRRS)疫苗產業分析

Research Report on China Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Industry, 2014-2018

出版商 China Research and Intelligence 商品編碼 288686
出版日期 內容資訊 英文 50 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
中國的豬隻繁殖、呼吸障礙症候群(PRRS)疫苗產業分析 Research Report on China Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Industry, 2014-2018
出版日期: 2014年09月17日 內容資訊: 英文 50 Pages
簡介

中國是全球最大的豬肉生產國、消費國,生產量佔整體將近50%。豬隻繁殖、呼吸障礙症候群(PRRS),發生在中國南部,2006年夏天後急速擴展到全國。現在,高病原性PRRS疫苗,由中國政府購買。

本報告提供中國的PRRS疫苗產業調查分析、市場的狀況、發展的影響要素、營運情形、主要製造商等相關的系統性資訊。

第1章 全球和中國的PRRS疫苗市場的狀況

  • PRRS疫苗的相關概念
    • PRRS定義
    • PRRS疫苗定義
  • PRRS的流行情形概要
    • PRRS的流行情形
    • 中國的PRRS的流行情形

第2章 中國的PRRS疫苗發展的影響要素

  • 中國的動物疫苗產業的政策
    • 動物防疫相關法律
    • 組織結構
    • 防疫的分配預算
    • 強制疫苗接種的範圍
    • PRRS的疫苗接種
  • 中國的養豬概要
    • 豬的家畜數量
    • 肥育豬的家畜數量
    • 豬肉的生產量

第3章 中國的PRRS疫苗產業的營運情形

  • PRRS疫苗的供給
    • 供給概要
    • 供給的影響要素
  • 需求
    • 需求概要
    • 需求的影響要素
  • 由政府免費提供的PRRS疫苗狀況
    • 現有的問題分析
    • 問題的解決辦法

第4章 中國的PRRS疫苗的主要製造商

  • 企業簡介、生產情形、開發策略
    • Guangdong Dahuanong Animal Health Products Co., Ltd.
    • Xinjiang Tecon Animal Husbandry Bio-Technology Co., Ltd.
    • Qingdao Yebio Bioengineering Co., Ltd.
    • Inner Mongolia Jinyu Group Stock Company

第5章 中國部分地方機構的PRRS疫苗購買狀況

  • 山東省的PRRS疫苗的得標情形
  • 山西省的PRRS疫苗的得標情形

第6章 中國的PRRS疫苗產業預測

  • 發展的影響要素
  • 供需預測

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: 1409177

China is the world's largest producer and consumer of pork with the output volume of pork accounting for nearly 50% of the total. The output volume of pork was 54.93 million tons in China in 2013, up by 2.8% YOY. The livestock volume of pigs was 474.11 million, down by 0.4% YOY while the stock volume of fattened pigs was 715.57 million, up by 2.5% YOY.

The PRRS broke out in southern China and spread rapidly nationwide after summer in 2006, which lead to increases in mortality rate of piglets and pork prices and significant decrease in output volume of pork. In May 2007, the Ministry of Agriculture of China approved the production of highly-pathogenic porcine reproductive and respiratory syndrome inactivated vaccine (NVDC-JXA1) in six manufacturers of biological products. Porcine reproductive and respiratory syndrome (PRRS) remains one of the key compulsory immunity diseases in China.

According to National Compulsory Immunization Plan of Animal Epidemic Diseases in 2014 issued by Ministry of Agriculture of China, the government conducts compulsory immunizations against 4 diseases, including highly-pathogenic PRRS. The government is responsible for the expenses. Currently highly pathogenic PRRS vaccines are purchased by the government through invitation for bidding in China.

The market competition is intensive in the PRRS vaccine industry in China. There are 26 manufacturers of PRRS vaccines in China, including Dahuanong, Xinjiang Tecon Animal Husbandry Bio-Technology Co., Ltd., Qingdao Yebio Bioengineering Co., Ltd. and Inner Mongolia Jinyu Group Stock Company. In terms of the direct sales of high-end vaccines, the PRRS vaccines of Zoetis went to the market in Guangzhou at the end of August 2013 after Boehringer. These foreign-funded vaccine brands occupy the market shares using the brand advantages, which intensify the market competition.

As Chinese economy develops and the living standards increase, the demand for pork will continue to grow, which promotes the development of pig raising industry. The market size of PRRS vaccines will continue to increase in China in the next few years, which attract many animal health enterprises' attention.

Through this report, the readers can acquire the following information:

  • Incidence Status of Porcine Reproductive and Respiratory Syndrome
  • Status of China Breeding Industry
  • Policy Environment and Government Procurement of PRRS Vaccines in China
  • Supply and Demand Status of PRRS Vaccines in China
  • Major Manufacturers of PRRS Vaccines and the Operation Status in China
  • Prospect of China PRRS Vaccine Industry in China

The Following Enterprises and People Are Recommended to Purchase This Report:

  • Manufacturers and Trading Enterprises of Animal Vaccines
  • Breeding Enterprises
  • Management Organizations of Livestock Industry
  • Investors and Research Institutes Concerned about PRRS Vaccine Industry

Table of Contents

1. Status of Global and China PRRS Vaccine Market

  • 1.1. Relevant Concepts of PRRS Vaccines
    • 1.1.1. Definition of PRRS
    • 1.1.2. Definition of PRRS Vaccine
  • 1.2. Brief Introduction of Epidemic Situation of PRRS
    • 1.2.1. Incidence Status of PRRS
    • 1.2.2. Epidemic Situation of PRRS in China

2. Factors Influencing Development of PRRS Vaccines in China, 2009-2013

  • 2.1. Policies in China Animal Vaccine Industry
    • 2.1.1. Legislation of Animal Epidemic Prevention
    • 2.1.2. Organization Structure
    • 2.1.3. Appropriation Budget of Epidemic Prevention
    • 2.1.4. Scope of Compulsory Immunization
    • 2.1.5. Immunization Policies on Highly-pathogenic PRRS
  • 2.2. Overview of Pig Breeding in China, 2009-2013
    • 2.2.1. Livestock Volume of Pigs
    • 2.2.2. Stock Volume of Fattened Pigs
    • 2.2.3. Output Volume of Pork

3. Operation Status of PRRS Vaccine Industry in China, 2009-2013

  • 3.1. Supply of PRRS Vaccines
    • 3.1.1. Supply Overview
    • 3.1.2. Factors Influencing Supply
  • 3.2. Demand
    • 3.2.1. Demand Overview
    • 3.2.2. Factors Influencing Demand
  • 3.3. Status of Free PRRS Vaccines Provided by the Government
    • 3.3.1. Analysis of Existing Problems
    • 3.3.2. Solutions to Problems

4. Major Manufacturers of PRRS Vaccines in China, 2011-2013

  • 4.1. Guangdong Dahuanong Animal Health Products Co., Ltd.
    • 4.1.1. Enterprise Profile
    • 4.1.2. Production Status of PRRS Vaccines
    • 4.1.3. Development Strategies of the Enterprise
  • 4.2. Xinjiang Tecon Animal Husbandry Bio-Technology Co., Ltd.
    • 4.2.1. Enterprise Profile
    • 4.2.2. Production Status of PRRS Vaccines
    • 4.2.3. Development Strategies
  • 4.3. Qingdao Yebio Bioengineering Co., Ltd.
    • 4.3.1. Enterprise Profile
    • 4.3.2. Production Status of PRRS Vaccines
    • 4.3.3. Development Strategies
  • 4.4. Inner Mongolia Jinyu Group Stock Company
    • 4.4.1. Enterprise Profile
    • 4.4.2. Production Status of PRRS Vaccines
    • 4.4.3. Development Strategies

5. Status of PRRS Vaccine Purchase in Some Local Governments in China, 2013

  • 5.1. Bid Winning Status of PRRS Vaccines in Shandong, 2013
    • 5.1.1. Bid Winning Enterprises and Products of PRRS Vaccines
    • 5.1.2. Bid Winning Prices
  • 5.2. Bid Winning Status of PRRS Vaccines in Shanxi, 2013
    • 5.2.1. Bid Winning Enterprises and Products of PRRS Vaccines
    • 5.2.2. Bid Winning Prices

6. Prospect of China PRRS Vaccine Industry, 2014-2018

  • 6.1. Factors Influencing Development
    • 6.1.1. Government Policies
    • 6.1.2. Pig Breeding
  • 6.2. Forecast on Supply and Demand
    • 6.2.1. Forecast on Supply of PRRS Vaccines
    • 6.2.2. Forecast on Demand for PRRS Vaccines

Selected Charts

  • Chart Epidemic Situation of PRRS in China, 2012-2014
  • Chart Expenses of Chinese Government on Animal Epidemic Prevention, 2009-2014
  • Chart Stock Volume of Fattened Pigs in China, 2009-2013
  • Chart Output Volume of Pork in China, 2009-2013
  • Chart Major Types of PRRS Vaccines in China
  • Chart Market Size of PRRS Vaccines in China, 2009-2013
  • Chart Forecast on Output Volume of PRRS Vaccines in China, 2014-2018
  • Chart Forecast on Market Size of PRRS Vaccines in China, 2014-2018
Back to Top